Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
(-)Biological Unit 3
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)
Image Biological Unit 3
Biological Unit 3  (Jmol Viewer)

(-) Description

Title :  INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, HOLO FORM.
 
Authors :  S. S. J. Lee, V. Knott, K. Harlos, P. A. Handford, D. I. Stuart
Date :  12 Mar 04  (Deposition) - 08 Apr 04  (Release) - 24 Feb 09  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.25
Chains :  Asym. Unit :  A,B,C
Biol. Unit 1:  A  (1x)
Biol. Unit 2:  B  (1x)
Biol. Unit 3:  C  (1x)
Keywords :  Matrix Protein, Extra-Cellular Matrix, Fibrillin-1, Cbegf Domain, Tb Domain Matrix Protein (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  S. S. J. Lee, V. Knott, J. Jovanovi, K. Harlos, J. Grimes, L. Choulier, H. Mardon, D. I. Stuart, P. A. Handford
Structure Of The Integrin Binding Fragment From Fibrillin-1 Gives New Insights Into Microfibril Organization
Structure V. 12 717 2004
PubMed-ID: 15062093  |  Reference-DOI: 10.1016/J.STR.2004.02.023

(-) Compounds

Molecule 1 - FIBRILLIN-1
    ChainsA, B, C
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System StrainNM554
    Expression System Taxid562
    FragmentBEGF22-TB4-CBEGF23, RESIDUES 1486-1647
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    TissueEXTRA-ELLULAR MATRIX

 Structural Features

(-) Chains, Units

  123
Asymmetric Unit ABC
Biological Unit 1 (1x)A  
Biological Unit 2 (1x) B 
Biological Unit 3 (1x)  C

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (1, 6)

Asymmetric Unit (1, 6)
No.NameCountTypeFull Name
1CA6Ligand/IonCALCIUM ION
Biological Unit 1 (0, 0)
No.NameCountTypeFull Name
1CA-1Ligand/IonCALCIUM ION
Biological Unit 2 (0, 0)
No.NameCountTypeFull Name
1CA-1Ligand/IonCALCIUM ION
Biological Unit 3 (0, 0)
No.NameCountTypeFull Name
1CA-1Ligand/IonCALCIUM ION

(-) Sites  (6, 6)

Asymmetric Unit (6, 6)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREASP A:1487 , VAL A:1488 , GLU A:1490 , ASN A:1504 , THR A:1505 , SER A:1508BINDING SITE FOR RESIDUE CA A1648
2AC2SOFTWAREASP A:1606 , ILE A:1607 , GLU A:1609 , ASN A:1624 , THR A:1625 , SER A:1628 , HOH A:2068BINDING SITE FOR RESIDUE CA A1649
3AC3SOFTWAREASP B:2487 , VAL B:2488 , GLU B:2490 , ASN B:2504 , THR B:2505 , GLY B:2507 , SER B:2508BINDING SITE FOR RESIDUE CA B2648
4AC4SOFTWAREHOH B:2067 , ASP B:2606 , ILE B:2607 , GLU B:2609 , ASN B:2624 , THR B:2625 , SER B:2628BINDING SITE FOR RESIDUE CA B2649
5AC5SOFTWAREASP C:3487 , VAL C:3488 , GLU C:3490 , ASN C:3504 , THR C:3505 , SER C:3508BINDING SITE FOR RESIDUE CA C3648
6AC6SOFTWAREASP C:3606 , ILE C:3607 , GLU C:3609 , ASN C:3624 , THR C:3625 , SER C:3628BINDING SITE FOR RESIDUE CA C3649

(-) SS Bonds  (30, 30)

Asymmetric Unit
No.Residues
1A:1491 -A:1502
2A:1497 -A:1511
3A:1513 -A:1526
4A:1534 -A:1562
5A:1549 -A:1574
6A:1563 -A:1577
7A:1564 -A:1589
8A:1610 -A:1622
9A:1617 -A:1631
10A:1633 -A:1646
11B:2491 -B:2502
12B:2497 -B:2511
13B:2513 -B:2526
14B:2534 -B:2562
15B:2549 -B:2574
16B:2563 -B:2577
17B:2564 -B:2589
18B:2610 -B:2622
19B:2617 -B:2631
20B:2633 -B:2646
21C:3491 -C:3502
22C:3497 -C:3511
23C:3513 -C:3526
24C:3534 -C:3562
25C:3549 -C:3574
26C:3563 -C:3577
27C:3564 -C:3589
28C:3610 -C:3622
29C:3617 -C:3631
30C:3633 -C:3646

(-) Cis Peptide Bonds  (3, 3)

Asymmetric Unit
No.Residues
1Thr A:1572 -Pro A:1573
2Thr B:2572 -Pro B:2573
3Thr C:3572 -Pro C:3573

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (18, 54)

Asymmetric Unit (18, 54)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_065998D1487AFBN1_HUMANDisease (MFS)  ---A
B
C
D1487
2487
3487
A
02UniProtVAR_065999N1489KFBN1_HUMANDisease (MFS)  ---A
B
C
N1489
2489
3489
K
03UniProtVAR_002326C1513RFBN1_HUMANDisease (MFS)  ---A
B
C
C1513
2513
3513
R
04UniProtVAR_076069D1528YFBN1_HUMANDisease (MFS)  ---A
B
C
D1528
2528
3528
Y
05UniProtVAR_018012R1530CFBN1_HUMANPolymorphism111401431A
B
C
R1530
2530
3530
C
06UniProtVAR_023886C1564FFBN1_HUMANDisease (MFS)  ---A
B
C
C1564
2564
3564
F
07UniProtVAR_064046C1564SFBN1_HUMANDisease (SSKS)  ---A
B
C
C1564
2564
3564
S
08UniProtVAR_018013C1564YFBN1_HUMANDisease (MFS)  ---A
B
C
C1564
2564
3564
Y
09UniProtVAR_064047W1570CFBN1_HUMANDisease (SSKS)  ---A
B
C
W1570
2570
3570
C
10UniProtVAR_023887M1576TFBN1_HUMANDisease (MFS)  ---A
B
C
M1576
2576
3576
T
11UniProtVAR_064048C1577GFBN1_HUMANDisease (SSKS)  ---A
B
C
C1577
2577
3577
G
12UniProtVAR_002327C1589FFBN1_HUMANDisease (MFS)  ---A
B
C
C1589
2589
3589
F
13UniProtVAR_064049G1594DFBN1_HUMANDisease (SSKS)  ---A
B
C
G1594
2594
3594
D
14UniProtVAR_002328C1610GFBN1_HUMANDisease (MFS)  ---A
B
C
C1610
2610
3610
G
15UniProtVAR_076073C1622RFBN1_HUMANDisease (MFS)  ---A
B
C
C1622
2622
3622
R
16UniProtVAR_023888C1631GFBN1_HUMANDisease (MFS)  ---A
B
C
C1631
2631
3631
G
17UniProtVAR_076074C1633SFBN1_HUMANDisease  ---A
B
C
C1633
2633
3633
S
18UniProtVAR_076075D1642GFBN1_HUMANDisease (MFS)  ---A
B
C
D1642
2642
3642
G

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (18, 18)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_065998D1487AFBN1_HUMANDisease (MFS)  ---A
B
A
D1487
2487
3487
A
02UniProtVAR_065999N1489KFBN1_HUMANDisease (MFS)  ---A
B
A
N1489
2489
3489
K
03UniProtVAR_002326C1513RFBN1_HUMANDisease (MFS)  ---A
B
A
C1513
2513
3513
R
04UniProtVAR_076069D1528YFBN1_HUMANDisease (MFS)  ---A
B
A
D1528
2528
3528
Y
05UniProtVAR_018012R1530CFBN1_HUMANPolymorphism111401431A
B
A
R1530
2530
3530
C
06UniProtVAR_023886C1564FFBN1_HUMANDisease (MFS)  ---A
B
A
C1564
2564
3564
F
07UniProtVAR_064046C1564SFBN1_HUMANDisease (SSKS)  ---A
B
A
C1564
2564
3564
S
08UniProtVAR_018013C1564YFBN1_HUMANDisease (MFS)  ---A
B
A
C1564
2564
3564
Y
09UniProtVAR_064047W1570CFBN1_HUMANDisease (SSKS)  ---A
B
A
W1570
2570
3570
C
10UniProtVAR_023887M1576TFBN1_HUMANDisease (MFS)  ---A
B
A
M1576
2576
3576
T
11UniProtVAR_064048C1577GFBN1_HUMANDisease (SSKS)  ---A
B
A
C1577
2577
3577
G
12UniProtVAR_002327C1589FFBN1_HUMANDisease (MFS)  ---A
B
A
C1589
2589
3589
F
13UniProtVAR_064049G1594DFBN1_HUMANDisease (SSKS)  ---A
B
A
G1594
2594
3594
D
14UniProtVAR_002328C1610GFBN1_HUMANDisease (MFS)  ---A
B
A
C1610
2610
3610
G
15UniProtVAR_076073C1622RFBN1_HUMANDisease (MFS)  ---A
B
A
C1622
2622
3622
R
16UniProtVAR_023888C1631GFBN1_HUMANDisease (MFS)  ---A
B
A
C1631
2631
3631
G
17UniProtVAR_076074C1633SFBN1_HUMANDisease  ---A
B
A
C1633
2633
3633
S
18UniProtVAR_076075D1642GFBN1_HUMANDisease (MFS)  ---A
B
A
D1642
2642
3642
G

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (18, 18)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_065998D1487AFBN1_HUMANDisease (MFS)  ---A
B
B
D1487
2487
3487
A
02UniProtVAR_065999N1489KFBN1_HUMANDisease (MFS)  ---A
B
B
N1489
2489
3489
K
03UniProtVAR_002326C1513RFBN1_HUMANDisease (MFS)  ---A
B
B
C1513
2513
3513
R
04UniProtVAR_076069D1528YFBN1_HUMANDisease (MFS)  ---A
B
B
D1528
2528
3528
Y
05UniProtVAR_018012R1530CFBN1_HUMANPolymorphism111401431A
B
B
R1530
2530
3530
C
06UniProtVAR_023886C1564FFBN1_HUMANDisease (MFS)  ---A
B
B
C1564
2564
3564
F
07UniProtVAR_064046C1564SFBN1_HUMANDisease (SSKS)  ---A
B
B
C1564
2564
3564
S
08UniProtVAR_018013C1564YFBN1_HUMANDisease (MFS)  ---A
B
B
C1564
2564
3564
Y
09UniProtVAR_064047W1570CFBN1_HUMANDisease (SSKS)  ---A
B
B
W1570
2570
3570
C
10UniProtVAR_023887M1576TFBN1_HUMANDisease (MFS)  ---A
B
B
M1576
2576
3576
T
11UniProtVAR_064048C1577GFBN1_HUMANDisease (SSKS)  ---A
B
B
C1577
2577
3577
G
12UniProtVAR_002327C1589FFBN1_HUMANDisease (MFS)  ---A
B
B
C1589
2589
3589
F
13UniProtVAR_064049G1594DFBN1_HUMANDisease (SSKS)  ---A
B
B
G1594
2594
3594
D
14UniProtVAR_002328C1610GFBN1_HUMANDisease (MFS)  ---A
B
B
C1610
2610
3610
G
15UniProtVAR_076073C1622RFBN1_HUMANDisease (MFS)  ---A
B
B
C1622
2622
3622
R
16UniProtVAR_023888C1631GFBN1_HUMANDisease (MFS)  ---A
B
B
C1631
2631
3631
G
17UniProtVAR_076074C1633SFBN1_HUMANDisease  ---A
B
B
C1633
2633
3633
S
18UniProtVAR_076075D1642GFBN1_HUMANDisease (MFS)  ---A
B
B
D1642
2642
3642
G

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 3 (18, 18)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_065998D1487AFBN1_HUMANDisease (MFS)  ---A
B
C
D1487
2487
3487
A
02UniProtVAR_065999N1489KFBN1_HUMANDisease (MFS)  ---A
B
C
N1489
2489
3489
K
03UniProtVAR_002326C1513RFBN1_HUMANDisease (MFS)  ---A
B
C
C1513
2513
3513
R
04UniProtVAR_076069D1528YFBN1_HUMANDisease (MFS)  ---A
B
C
D1528
2528
3528
Y
05UniProtVAR_018012R1530CFBN1_HUMANPolymorphism111401431A
B
C
R1530
2530
3530
C
06UniProtVAR_023886C1564FFBN1_HUMANDisease (MFS)  ---A
B
C
C1564
2564
3564
F
07UniProtVAR_064046C1564SFBN1_HUMANDisease (SSKS)  ---A
B
C
C1564
2564
3564
S
08UniProtVAR_018013C1564YFBN1_HUMANDisease (MFS)  ---A
B
C
C1564
2564
3564
Y
09UniProtVAR_064047W1570CFBN1_HUMANDisease (SSKS)  ---A
B
C
W1570
2570
3570
C
10UniProtVAR_023887M1576TFBN1_HUMANDisease (MFS)  ---A
B
C
M1576
2576
3576
T
11UniProtVAR_064048C1577GFBN1_HUMANDisease (SSKS)  ---A
B
C
C1577
2577
3577
G
12UniProtVAR_002327C1589FFBN1_HUMANDisease (MFS)  ---A
B
C
C1589
2589
3589
F
13UniProtVAR_064049G1594DFBN1_HUMANDisease (SSKS)  ---A
B
C
G1594
2594
3594
D
14UniProtVAR_002328C1610GFBN1_HUMANDisease (MFS)  ---A
B
C
C1610
2610
3610
G
15UniProtVAR_076073C1622RFBN1_HUMANDisease (MFS)  ---A
B
C
C1622
2622
3622
R
16UniProtVAR_023888C1631GFBN1_HUMANDisease (MFS)  ---A
B
C
C1631
2631
3631
G
17UniProtVAR_076074C1633SFBN1_HUMANDisease  ---A
B
C
C1633
2633
3633
S
18UniProtVAR_076075D1642GFBN1_HUMANDisease (MFS)  ---A
B
C
D1642
2642
3642
G

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (5, 24)

Asymmetric Unit (5, 24)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1EGF_2PS01186 EGF-like domain signature 2.FBN1_HUMAN134-145
166-177
313-328
474-488
513-528
555-570
596-611
748-763
790-805
1053-1068
1180-1195
1221-1236
1263-1278
1305-1320
1348-1361
1389-1402
1429-1444
1470-1485
1631-1646
 
 
1791-1806
1833-1847
1874-1889
1914-1928
1956-1971
1998-2011
2038-2053
2151-2164
2190-2204
2230-2245
2274-2289
2316-2331
2427-2442
2468-2483
2509-2522
2550-2565
2590-2605
2631-2646
2672-2686
  3-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
A:1631-1646
B:2631-2646
C:3631-3646
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2EGF_3PS50026 EGF-like domain profile.FBN1_HUMAN146-178
246-287
288-329
490-525
530-571
572-612
613-653
723-764
765-806
807-846
910-951
1028-1069
1070-1112
1113-1154
1155-1196
1197-1237
1238-1279
1280-1317
1322-1362
1363-1401
1404-1445
1446-1482
1487-1527
 
 
1606-1647
 
 
1648-1684
1766-1807
1808-1848
1849-1886
1891-1926
1930-1972
1973-2012
2013-2054
2127-2165
2166-2205
2206-2246
2247-2290
2291-2332
2402-2439
2444-2484
2485-2521
2524-2566
2567-2606
2607-2643
2648-2687
  6-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
A:1487-1527
B:2487-2527
C:3487-3527
A:1606-1647
B:2606-2647
C:3606-3647
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
3TBPS51364 TGF-beta binding (TB) domain profile.FBN1_HUMAN184-227
334-389
659-711
851-890
956-1008
1532-1589
 
 
1693-1748
2059-2111
2337-2390
  3-
-
-
-
-
A:1532-1589
B:2532-2589
C:3532-3589
-
-
-
4EGF_CAPS01187 Calcium-binding EGF-like domain signature.FBN1_HUMAN246-271
288-313
490-513
530-555
572-596
613-637
723-748
765-790
807-830
910-935
1028-1053
1070-1095
1113-1138
1155-1180
1197-1221
1238-1263
1280-1305
1322-1348
1363-1389
1404-1429
1446-1470
1487-1511
 
 
1606-1631
 
 
1648-1672
1766-1791
1808-1833
1849-1874
1891-1914
1930-1956
1973-1998
2013-2038
2127-2151
2166-2190
2206-2230
2247-2274
2291-2316
2402-2427
2444-2468
2485-2509
2524-2550
2567-2590
2601-2631
2648-2672
  6-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
A:1487-1511
B:2487-2511
C:3487-3511
A:1606-1631
B:2606-2631
C:3606-3631
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
5ASX_HYDROXYLPS00010 Aspartic acid and asparagine hydroxylation site.FBN1_HUMAN262-273
304-315
504-515
546-557
587-598
628-639
739-750
781-792
821-832
926-937
1044-1055
1086-1097
1129-1140
1171-1182
1212-1223
1254-1265
1296-1307
1339-1350
1380-1391
1420-1431
1461-1472
1502-1513
 
 
1622-1633
 
 
1663-1674
1782-1793
1824-1835
1865-1876
1905-1916
1947-1958
1989-2000
2029-2040
2142-2153
2181-2192
2221-2232
2265-2276
2307-2318
2418-2429
2459-2470
2500-2511
2541-2552
2581-2592
2622-2633
2663-2674
  6-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
A:1502-1513
B:2502-2513
C:3502-3513
A:1622-1633
B:2622-2633
C:3622-3633
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Biological Unit 1 (5, 8)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1EGF_2PS01186 EGF-like domain signature 2.FBN1_HUMAN134-145
166-177
313-328
474-488
513-528
555-570
596-611
748-763
790-805
1053-1068
1180-1195
1221-1236
1263-1278
1305-1320
1348-1361
1389-1402
1429-1444
1470-1485
1631-1646
 
 
1791-1806
1833-1847
1874-1889
1914-1928
1956-1971
1998-2011
2038-2053
2151-2164
2190-2204
2230-2245
2274-2289
2316-2331
2427-2442
2468-2483
2509-2522
2550-2565
2590-2605
2631-2646
2672-2686
  1-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
A:1631-1646
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2EGF_3PS50026 EGF-like domain profile.FBN1_HUMAN146-178
246-287
288-329
490-525
530-571
572-612
613-653
723-764
765-806
807-846
910-951
1028-1069
1070-1112
1113-1154
1155-1196
1197-1237
1238-1279
1280-1317
1322-1362
1363-1401
1404-1445
1446-1482
1487-1527
 
 
1606-1647
 
 
1648-1684
1766-1807
1808-1848
1849-1886
1891-1926
1930-1972
1973-2012
2013-2054
2127-2165
2166-2205
2206-2246
2247-2290
2291-2332
2402-2439
2444-2484
2485-2521
2524-2566
2567-2606
2607-2643
2648-2687
  2-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
A:1487-1527
-
-
A:1606-1647
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
3TBPS51364 TGF-beta binding (TB) domain profile.FBN1_HUMAN184-227
334-389
659-711
851-890
956-1008
1532-1589
 
 
1693-1748
2059-2111
2337-2390
  1-
-
-
-
-
A:1532-1589
-
-
-
-
-
4EGF_CAPS01187 Calcium-binding EGF-like domain signature.FBN1_HUMAN246-271
288-313
490-513
530-555
572-596
613-637
723-748
765-790
807-830
910-935
1028-1053
1070-1095
1113-1138
1155-1180
1197-1221
1238-1263
1280-1305
1322-1348
1363-1389
1404-1429
1446-1470
1487-1511
 
 
1606-1631
 
 
1648-1672
1766-1791
1808-1833
1849-1874
1891-1914
1930-1956
1973-1998
2013-2038
2127-2151
2166-2190
2206-2230
2247-2274
2291-2316
2402-2427
2444-2468
2485-2509
2524-2550
2567-2590
2601-2631
2648-2672
  2-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
A:1487-1511
-
-
A:1606-1631
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
5ASX_HYDROXYLPS00010 Aspartic acid and asparagine hydroxylation site.FBN1_HUMAN262-273
304-315
504-515
546-557
587-598
628-639
739-750
781-792
821-832
926-937
1044-1055
1086-1097
1129-1140
1171-1182
1212-1223
1254-1265
1296-1307
1339-1350
1380-1391
1420-1431
1461-1472
1502-1513
 
 
1622-1633
 
 
1663-1674
1782-1793
1824-1835
1865-1876
1905-1916
1947-1958
1989-2000
2029-2040
2142-2153
2181-2192
2221-2232
2265-2276
2307-2318
2418-2429
2459-2470
2500-2511
2541-2552
2581-2592
2622-2633
2663-2674
  2-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
A:1502-1513
-
-
A:1622-1633
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Biological Unit 2 (5, 8)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1EGF_2PS01186 EGF-like domain signature 2.FBN1_HUMAN134-145
166-177
313-328
474-488
513-528
555-570
596-611
748-763
790-805
1053-1068
1180-1195
1221-1236
1263-1278
1305-1320
1348-1361
1389-1402
1429-1444
1470-1485
1631-1646
 
 
1791-1806
1833-1847
1874-1889
1914-1928
1956-1971
1998-2011
2038-2053
2151-2164
2190-2204
2230-2245
2274-2289
2316-2331
2427-2442
2468-2483
2509-2522
2550-2565
2590-2605
2631-2646
2672-2686
  1-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
B:2631-2646
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2EGF_3PS50026 EGF-like domain profile.FBN1_HUMAN146-178
246-287
288-329
490-525
530-571
572-612
613-653
723-764
765-806
807-846
910-951
1028-1069
1070-1112
1113-1154
1155-1196
1197-1237
1238-1279
1280-1317
1322-1362
1363-1401
1404-1445
1446-1482
1487-1527
 
 
1606-1647
 
 
1648-1684
1766-1807
1808-1848
1849-1886
1891-1926
1930-1972
1973-2012
2013-2054
2127-2165
2166-2205
2206-2246
2247-2290
2291-2332
2402-2439
2444-2484
2485-2521
2524-2566
2567-2606
2607-2643
2648-2687
  2-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
B:2487-2527
-
-
B:2606-2647
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
3TBPS51364 TGF-beta binding (TB) domain profile.FBN1_HUMAN184-227
334-389
659-711
851-890
956-1008
1532-1589
 
 
1693-1748
2059-2111
2337-2390
  1-
-
-
-
-
-
B:2532-2589
-
-
-
-
4EGF_CAPS01187 Calcium-binding EGF-like domain signature.FBN1_HUMAN246-271
288-313
490-513
530-555
572-596
613-637
723-748
765-790
807-830
910-935
1028-1053
1070-1095
1113-1138
1155-1180
1197-1221
1238-1263
1280-1305
1322-1348
1363-1389
1404-1429
1446-1470
1487-1511
 
 
1606-1631
 
 
1648-1672
1766-1791
1808-1833
1849-1874
1891-1914
1930-1956
1973-1998
2013-2038
2127-2151
2166-2190
2206-2230
2247-2274
2291-2316
2402-2427
2444-2468
2485-2509
2524-2550
2567-2590
2601-2631
2648-2672
  2-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
B:2487-2511
-
-
B:2606-2631
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
5ASX_HYDROXYLPS00010 Aspartic acid and asparagine hydroxylation site.FBN1_HUMAN262-273
304-315
504-515
546-557
587-598
628-639
739-750
781-792
821-832
926-937
1044-1055
1086-1097
1129-1140
1171-1182
1212-1223
1254-1265
1296-1307
1339-1350
1380-1391
1420-1431
1461-1472
1502-1513
 
 
1622-1633
 
 
1663-1674
1782-1793
1824-1835
1865-1876
1905-1916
1947-1958
1989-2000
2029-2040
2142-2153
2181-2192
2221-2232
2265-2276
2307-2318
2418-2429
2459-2470
2500-2511
2541-2552
2581-2592
2622-2633
2663-2674
  2-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
B:2502-2513
-
-
B:2622-2633
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Biological Unit 3 (5, 8)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1EGF_2PS01186 EGF-like domain signature 2.FBN1_HUMAN134-145
166-177
313-328
474-488
513-528
555-570
596-611
748-763
790-805
1053-1068
1180-1195
1221-1236
1263-1278
1305-1320
1348-1361
1389-1402
1429-1444
1470-1485
1631-1646
 
 
1791-1806
1833-1847
1874-1889
1914-1928
1956-1971
1998-2011
2038-2053
2151-2164
2190-2204
2230-2245
2274-2289
2316-2331
2427-2442
2468-2483
2509-2522
2550-2565
2590-2605
2631-2646
2672-2686
  1-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
C:3631-3646
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2EGF_3PS50026 EGF-like domain profile.FBN1_HUMAN146-178
246-287
288-329
490-525
530-571
572-612
613-653
723-764
765-806
807-846
910-951
1028-1069
1070-1112
1113-1154
1155-1196
1197-1237
1238-1279
1280-1317
1322-1362
1363-1401
1404-1445
1446-1482
1487-1527
 
 
1606-1647
 
 
1648-1684
1766-1807
1808-1848
1849-1886
1891-1926
1930-1972
1973-2012
2013-2054
2127-2165
2166-2205
2206-2246
2247-2290
2291-2332
2402-2439
2444-2484
2485-2521
2524-2566
2567-2606
2607-2643
2648-2687
  2-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
C:3487-3527
-
-
C:3606-3647
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
3TBPS51364 TGF-beta binding (TB) domain profile.FBN1_HUMAN184-227
334-389
659-711
851-890
956-1008
1532-1589
 
 
1693-1748
2059-2111
2337-2390
  1-
-
-
-
-
-
-
C:3532-3589
-
-
-
4EGF_CAPS01187 Calcium-binding EGF-like domain signature.FBN1_HUMAN246-271
288-313
490-513
530-555
572-596
613-637
723-748
765-790
807-830
910-935
1028-1053
1070-1095
1113-1138
1155-1180
1197-1221
1238-1263
1280-1305
1322-1348
1363-1389
1404-1429
1446-1470
1487-1511
 
 
1606-1631
 
 
1648-1672
1766-1791
1808-1833
1849-1874
1891-1914
1930-1956
1973-1998
2013-2038
2127-2151
2166-2190
2206-2230
2247-2274
2291-2316
2402-2427
2444-2468
2485-2509
2524-2550
2567-2590
2601-2631
2648-2672
  2-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
C:3487-3511
-
-
C:3606-3631
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
5ASX_HYDROXYLPS00010 Aspartic acid and asparagine hydroxylation site.FBN1_HUMAN262-273
304-315
504-515
546-557
587-598
628-639
739-750
781-792
821-832
926-937
1044-1055
1086-1097
1129-1140
1171-1182
1212-1223
1254-1265
1296-1307
1339-1350
1380-1391
1420-1431
1461-1472
1502-1513
 
 
1622-1633
 
 
1663-1674
1782-1793
1824-1835
1865-1876
1905-1916
1947-1958
1989-2000
2029-2040
2142-2153
2181-2192
2221-2232
2265-2276
2307-2318
2418-2429
2459-2470
2500-2511
2541-2552
2581-2592
2622-2633
2663-2674
  2-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
C:3502-3513
-
-
C:3622-3633
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

(-) Exons   (5, 15)

Asymmetric Unit (5, 15)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1ENST000003166231ENSE00001525471chr15:48937918-48937772147FBN1_HUMAN-00--
1.2ENST000003166232ENSE00002176401chr15:48937147-48936803345FBN1_HUMAN1-55550--
1.3ENST000003166233ENSE00001761744chr15:48905289-4890520783FBN1_HUMAN55-83290--
1.4ENST000003166234ENSE00001729100chr15:48903023-4890292599FBN1_HUMAN83-116340--
1.5ENST000003166235ENSE00001737946chr15:48892431-4889233696FBN1_HUMAN116-148330--
1.6ENST000003166236ENSE00001783191chr15:48888575-4888848096FBN1_HUMAN148-180330--
1.7ENST000003166237ENSE00001764592chr15:48830005-48829808198FBN1_HUMAN180-246670--
1.8ENST000003166238ENSE00001793339chr15:48826402-48826277126FBN1_HUMAN246-288430--
1.9ENST000003166239ENSE00001771562chr15:48818452-48818327126FBN1_HUMAN288-330430--
1.10ENST0000031662310ENSE00001744589chr15:48813014-48812856159FBN1_HUMAN330-383540--
1.11ENST0000031662311ENSE00001699841chr15:48808559-48808380180FBN1_HUMAN383-443610--
1.12ENST0000031662312ENSE00001599991chr15:48807724-48807584141FBN1_HUMAN443-490480--
1.13ENST0000031662313ENSE00001788059chr15:48805865-48805746120FBN1_HUMAN490-530410--
1.14ENST0000031662314ENSE00001675795chr15:48802366-48802241126FBN1_HUMAN530-572430--
1.15ENST0000031662315ENSE00001666782chr15:48800901-48800779123FBN1_HUMAN572-613420--
1.16ENST0000031662316ENSE00001721875chr15:48797344-48797222123FBN1_HUMAN613-654420--
1.17ENST0000031662317ENSE00001715942chr15:48796136-48795984153FBN1_HUMAN654-705520--
1.18ENST0000031662318ENSE00001640683chr15:48791235-4879118254FBN1_HUMAN705-723190--
1.19ENST0000031662319ENSE00001612341chr15:48789588-48789463126FBN1_HUMAN723-765430--
1.20ENST0000031662320ENSE00001630897chr15:48788422-48788297126FBN1_HUMAN765-807430--
1.21ENST0000031662321ENSE00001772761chr15:48787785-48787666120FBN1_HUMAN807-847410--
1.22ENST0000031662322ENSE00001661869chr15:48787457-48787320138FBN1_HUMAN847-893470--
1.23ENST0000031662323ENSE00001788284chr15:48786451-4878640151FBN1_HUMAN893-910180--
1.24ENST0000031662324ENSE00001769793chr15:48784783-48784658126FBN1_HUMAN910-952430--
1.25ENST0000031662325ENSE00001717687chr15:48782275-48782048228FBN1_HUMAN952-1028770--
1.26ENST0000031662326ENSE00001613423chr15:48780690-48780565126FBN1_HUMAN1028-1070430--
1.27ENST0000031662327ENSE00001762721chr15:48780438-48780310129FBN1_HUMAN1070-1113440--
1.28ENST0000031662328ENSE00001641154chr15:48779634-48779509126FBN1_HUMAN1113-1155430--
1.29ENST0000031662329ENSE00001800492chr15:48779397-48779272126FBN1_HUMAN1155-1197430--
1.30ENST0000031662330ENSE00001620699chr15:48777693-48777571123FBN1_HUMAN1197-1238420--
1.31ENST0000031662331ENSE00001613453chr15:48776140-48776015126FBN1_HUMAN1238-1280430--
1.32ENST0000031662332ENSE00001753582chr15:48773977-48773852126FBN1_HUMAN1280-1322430--
1.33ENST0000031662333ENSE00001628258chr15:48766847-48766725123FBN1_HUMAN1322-1363420--
1.34ENST0000031662334ENSE00001770461chr15:48766574-48766452123FBN1_HUMAN1363-1404420--
1.35ENST0000031662335ENSE00001613724chr15:48764873-48764748126FBN1_HUMAN1404-1446430--
1.36ENST0000031662336ENSE00000884505chr15:48762953-48762831123FBN1_HUMAN1446-1487423A:1486-1487
B:2486-2487
C:3486-3487
2
2
2
1.37ENST0000031662337ENSE00000884504chr15:48760731-48760609123FBN1_HUMAN1487-1528423A:1487-1528
B:2487-2528
C:3487-3528
42
42
42
1.38ENST0000031662338ENSE00000686984chr15:48760299-48760135165FBN1_HUMAN1528-1583563A:1528-1583
B:2528-2583
C:3528-3583
56
56
56
1.39ENST0000031662339ENSE00000686980chr15:48758055-4875798769FBN1_HUMAN1583-1606243A:1583-1606
B:2583-2606
C:3583-3606
24
24
24
1.40ENST0000031662340ENSE00000686976chr15:48757890-48757765126FBN1_HUMAN1606-1648433A:1606-1647
B:2606-2647
C:3606-3647
42
42
42
1.41ENST0000031662341ENSE00000884503chr15:48756218-48756096123FBN1_HUMAN1648-1689420--
1.42ENST0000031662342ENSE00000686967chr15:48755437-48755279159FBN1_HUMAN1689-1742540--
1.43ENST0000031662343ENSE00001175019chr15:48752514-4875244372FBN1_HUMAN1742-1766250--
1.44ENST0000031662344ENSE00000884501chr15:48748959-48748834126FBN1_HUMAN1766-1808430--
1.45ENST0000031662345ENSE00000884500chr15:48744881-48744759123FBN1_HUMAN1808-1849420--
1.46ENST0000031662346ENSE00001181714chr15:48741090-48740965126FBN1_HUMAN1849-1891430--
1.47ENST0000031662347ENSE00001175887chr15:48739019-48738903117FBN1_HUMAN1891-1930400--
1.48ENST0000031662348ENSE00000884497chr15:48737701-48737573129FBN1_HUMAN1930-1973440--
1.49ENST0000031662349ENSE00000884496chr15:48736857-48736738120FBN1_HUMAN1973-2013410--
1.50ENST0000031662350ENSE00000884495chr15:48734043-48733918126FBN1_HUMAN2013-2055430--
1.51ENST0000031662351ENSE00000884494chr15:48730114-48729965150FBN1_HUMAN2055-2105510--
1.52ENST0000031662352ENSE00000884493chr15:48729584-4872951966FBN1_HUMAN2105-2127230--
1.53ENST0000031662353ENSE00000884492chr15:48729274-48729158117FBN1_HUMAN2127-2166400--
1.54ENST0000031662354ENSE00001721904chr15:48726910-48726791120FBN1_HUMAN2166-2206410--
1.55ENST0000031662355ENSE00001759584chr15:48725185-48725063123FBN1_HUMAN2206-2247420--
1.56ENST0000031662356ENSE00000884489chr15:48722999-48722868132FBN1_HUMAN2247-2291450--
1.57ENST0000031662357ENSE00000884488chr15:48720668-48720543126FBN1_HUMAN2291-2333430--
1.59ENST0000031662359ENSE00001682471chr15:48719970-48719764207FBN1_HUMAN2333-2402700--
1.60ENST0000031662360ENSE00001657678chr15:48718061-48717936126FBN1_HUMAN2402-2444430--
1.61ENST0000031662361ENSE00001705569chr15:48717688-48717566123FBN1_HUMAN2444-2485420--
1.62ENST0000031662362ENSE00001770578chr15:48714265-48714149117FBN1_HUMAN2485-2524400--
1.63ENST0000031662363ENSE00001771268chr15:48713883-48713755129FBN1_HUMAN2524-2567440--
1.64ENST0000031662364ENSE00001767848chr15:48713003-48712884120FBN1_HUMAN2567-2607410--
1.65ENST0000031662365ENSE00001743300chr15:48707964-48707733232FBN1_HUMAN2607-2684780--
1.66ENST0000031662366ENSE00001804196chr15:48704940-48704766175FBN1_HUMAN2684-2742590--
1.67ENST0000031662367ENSE00001662441chr15:48703576-487005053072FBN1_HUMAN2743-28711290--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:162
 aligned with FBN1_HUMAN | P35555 from UniProtKB/Swiss-Prot  Length:2871

    Alignment length:162
                                  1495      1505      1515      1525      1535      1545      1555      1565      1575      1585      1595      1605      1615      1625      1635      1645  
          FBN1_HUMAN   1486 TDVNECLDPTTCISGNCVNTPGSYICDCPPDFELNPTRVGCVDTRSGNCYLDIRPRGDNGDTACSNEIGVGVSKASCCCSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPITVILEDIDECQELPGLCQGGKCINTFGSFQCRCPTGYYLNEDTRVCD 1647
               SCOP domains d1uzja1 A:1486-1528 Fibrillin-1            d1uzja3 A:1529-1604 Fibrillin                                               d1uzja2 A:1605-1647 Fibrillin-1             SCOP domains
               CATH domains 1uzjA01 A:1486-1530 Laminin                  --------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ...hhhhh.......eeee....eeee.....ee......ee....eeeeee............eeeeeeeehhhhhhh....ee....ee.....hhhhhhhh.....eee......eee.hhhhhhhhhh...eeeee..eeeee......ee....ee. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                PROSITE (1) -EGF_3  PDB: A:1487-1527                  ----TB  PDB: A:1532-1589 UniProt: 1532-1589                   -----------------------------------------EGF_2           - PROSITE (1)
                PROSITE (2) -EGF_CA  PDB: A:1487-1511 ----------------------------------------------------------------------------------------------EGF_3  PDB: A:1606-1647 UniProt: 1606-1647 PROSITE (2)
                PROSITE (3) ----------------ASX_HYDROXYL--------------------------------------------------------------------------------------------EGF_CA  PDB: A:1606-1631  ---------------- PROSITE (3)
                PROSITE (4) ----------------------------------------------------------------------------------------------------------------------------------------ASX_HYDROXYL-------------- PROSITE (4)
           Transcript 1 (1) 1.----------------------------------------Exon 1.38  PDB: A:1528-1583 UniProt: 1528-1583          ----------------------Exon 1.40  PDB: A:1606-1647 [INCOMPLETE]   Transcript 1 (1)
           Transcript 1 (2) -Exon 1.37  PDB: A:1487-1528               ------------------------------------------------------Exon 1.39               ----------------------------------------- Transcript 1 (2)
                1uzj A 1486 TDVNECLDPTTCISGNCVNTPGSYICDCPPDFELNPTRVGCVDTRSGNCYLDIRPRGDNGDTACSNEIGVGVSKASCCCSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPITVILEDIDECQELPGLCQGGKCINTFGSFQCRCPTGYYLNEDTRVCD 1647
                                  1495      1505      1515      1525      1535      1545      1555      1565      1575      1585      1595      1605      1615      1625      1635      1645  

Chain B from PDB  Type:PROTEIN  Length:162
 aligned with FBN1_HUMAN | P35555 from UniProtKB/Swiss-Prot  Length:2871

    Alignment length:162
                                  1495      1505      1515      1525      1535      1545      1555      1565      1575      1585      1595      1605      1615      1625      1635      1645  
          FBN1_HUMAN   1486 TDVNECLDPTTCISGNCVNTPGSYICDCPPDFELNPTRVGCVDTRSGNCYLDIRPRGDNGDTACSNEIGVGVSKASCCCSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPITVILEDIDECQELPGLCQGGKCINTFGSFQCRCPTGYYLNEDTRVCD 1647
               SCOP domains d1uzjb1 B:2486-2528 Fibrillin-1            d1uzjb3 B:2529-2604 Fibrillin                                               d1uzjb2 B:2605-2647 Fibrillin-1             SCOP domains
               CATH domains 1uzjB01 B:2486-2530 Laminin                  --------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ...hhhhh.......eeee....eeee.....ee......ee....eeeeee............eeeeeeeehhhhhhh....ee....ee.....hhhhhhhh.....eee......eee.hhhhhhhhhh...eeeee..eeeee......ee....ee. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                PROSITE (1) -EGF_3  PDB: B:2487-2527                  ----TB  PDB: B:2532-2589 UniProt: 1532-1589                   -----------------------------------------EGF_2           - PROSITE (1)
                PROSITE (2) -EGF_CA  PDB: B:2487-2511 ----------------------------------------------------------------------------------------------EGF_3  PDB: B:2606-2647 UniProt: 1606-1647 PROSITE (2)
                PROSITE (3) ----------------ASX_HYDROXYL--------------------------------------------------------------------------------------------EGF_CA  PDB: B:2606-2631  ---------------- PROSITE (3)
                PROSITE (4) ----------------------------------------------------------------------------------------------------------------------------------------ASX_HYDROXYL-------------- PROSITE (4)
           Transcript 1 (1) 1.----------------------------------------Exon 1.38  PDB: B:2528-2583 UniProt: 1528-1583          ----------------------Exon 1.40  PDB: B:2606-2647 [INCOMPLETE]   Transcript 1 (1)
           Transcript 1 (2) -Exon 1.37  PDB: B:2487-2528               ------------------------------------------------------Exon 1.39               ----------------------------------------- Transcript 1 (2)
                1uzj B 2486 TDVNECLDPTTCISGNCVNTPGSYICDCPPDFELNPTRVGCVDTRSGNCYLDIRPRGDNGDTACSNEIGVGVSKASCCCSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPITVILEDIDECQELPGLCQGGKCINTFGSFQCRCPTGYYLNEDTRVCD 2647
                                  2495      2505      2515      2525      2535      2545      2555      2565      2575      2585      2595      2605      2615      2625      2635      2645  

Chain C from PDB  Type:PROTEIN  Length:162
 aligned with FBN1_HUMAN | P35555 from UniProtKB/Swiss-Prot  Length:2871

    Alignment length:162
                                  1495      1505      1515      1525      1535      1545      1555      1565      1575      1585      1595      1605      1615      1625      1635      1645  
          FBN1_HUMAN   1486 TDVNECLDPTTCISGNCVNTPGSYICDCPPDFELNPTRVGCVDTRSGNCYLDIRPRGDNGDTACSNEIGVGVSKASCCCSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPITVILEDIDECQELPGLCQGGKCINTFGSFQCRCPTGYYLNEDTRVCD 1647
               SCOP domains d1uzjc1 C:3486-3528 Fibrillin-1            d1uzjc3 C:3529-3604 Fibrillin                                               d1uzjc2 C:3605-3647 Fibrillin-1             SCOP domains
               CATH domains 1uzjC01 C:3486-3530 Laminin                  --------------------------------------------------------------------------------------------------------------------- CATH domains
           Pfam domains (1) -------------------------------------------------------------TB-1uzjC07 C:3547-3588                    -----------------EGF_CA-1uzjC01 C:3606-3646               - Pfam domains (1)
           Pfam domains (2) -------------------------------------------------------------TB-1uzjC08 C:3547-3588                    -----------------EGF_CA-1uzjC02 C:3606-3646               - Pfam domains (2)
           Pfam domains (3) -------------------------------------------------------------TB-1uzjC09 C:3547-3588                    -----------------EGF_CA-1uzjC03 C:3606-3646               - Pfam domains (3)
           Pfam domains (4) ------------------------------------------------------------------------------------------------------------------------EGF_CA-1uzjC04 C:3606-3646               - Pfam domains (4)
           Pfam domains (5) ------------------------------------------------------------------------------------------------------------------------EGF_CA-1uzjC05 C:3606-3646               - Pfam domains (5)
           Pfam domains (6) ------------------------------------------------------------------------------------------------------------------------EGF_CA-1uzjC06 C:3606-3646               - Pfam domains (6)
         Sec.struct. author ...hhhhh.......eeeee..eeeee.....ee......ee....eeeeee............eeeeeeeehhhhhhh....ee...........hhhhhhhh.....eee......eee.hhhhhhhhhh...eeeee..eeeee......ee....ee. Sec.struct. author
             SAPs(SNPs) (1) -A-K-----------------------R--------------Y-C---------------------------------F-----C-----TG-----------F----D---------------G-----------R--------G-S--------G----- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------S----------------------------------------------------------------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------------------------------------------Y----------------------------------------------------------------------------------- SAPs(SNPs) (3)
                PROSITE (1) -EGF_3  PDB: C:3487-3527                  ----TB  PDB: C:3532-3589 UniProt: 1532-1589                   -----------------------------------------EGF_2           - PROSITE (1)
                PROSITE (2) -EGF_CA  PDB: C:3487-3511 ----------------------------------------------------------------------------------------------EGF_3  PDB: C:3606-3647 UniProt: 1606-1647 PROSITE (2)
                PROSITE (3) ----------------ASX_HYDROXYL--------------------------------------------------------------------------------------------EGF_CA  PDB: C:3606-3631  ---------------- PROSITE (3)
                PROSITE (4) ----------------------------------------------------------------------------------------------------------------------------------------ASX_HYDROXYL-------------- PROSITE (4)
           Transcript 1 (1) 1.----------------------------------------Exon 1.38  PDB: C:3528-3583 UniProt: 1528-1583          ----------------------Exon 1.40  PDB: C:3606-3647 [INCOMPLETE]   Transcript 1 (1)
           Transcript 1 (2) -Exon 1.37  PDB: C:3487-3528               ------------------------------------------------------Exon 1.39               ----------------------------------------- Transcript 1 (2)
                1uzj C 3486 TDVNECLDPTTCISGNCVNTPGSYICDCPPDFELNPTRVGCVDTRSGNCYLDIRPRGDNGDTACSNEIGVGVSKASCCCSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPITVILEDIDECQELPGLCQGGKCINTFGSFQCRCPTGYYLNEDTRVCD 3647
                                  3495      3505      3515      3525      3535      3545      3555      3565      3575      3585      3595      3605      3615      3625      3635      3645  

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (2, 9)

Asymmetric Unit

(-) CATH Domains  (1, 3)

Asymmetric Unit
(-)
Class: Mainly Beta (13760)
1a1uzjA01A:1486-1530
1b1uzjB01B:2486-2530
1c1uzjC01C:3486-3530

(-) Pfam Domains  (2, 9)

Asymmetric Unit
(-)
Clan: EGF (60)
(-)
Family: EGF_CA (18)
1aEGF_CA-1uzjC01C:3606-3646
1bEGF_CA-1uzjC02C:3606-3646
1cEGF_CA-1uzjC03C:3606-3646
1dEGF_CA-1uzjC04C:3606-3646
1eEGF_CA-1uzjC05C:3606-3646
1fEGF_CA-1uzjC06C:3606-3646
(-)
Family: TB (5)
2aTB-1uzjC07C:3547-3588
2bTB-1uzjC08C:3547-3588
2cTB-1uzjC09C:3547-3588

(-) Gene Ontology  (27, 27)

Asymmetric Unit(hide GO term definitions)
Chain A,B,C   (FBN1_HUMAN | P35555)
molecular function
    GO:0005509    calcium ion binding    Interacting selectively and non-covalently with calcium ions (Ca2+).
    GO:0030023    extracellular matrix constituent conferring elasticity    A component of the extracellular matrix that enables the matrix to recoil after transient stretching.
    GO:0005201    extracellular matrix structural constituent    The action of a molecule that contributes to the structural integrity of the extracellular matrix.
    GO:0005178    integrin binding    Interacting selectively and non-covalently with an integrin.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0032403    protein complex binding    Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules).
biological process
    GO:0043010    camera-type eye development    The process whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
    GO:1990314    cellular response to insulin-like growth factor stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
    GO:0071560    cellular response to transforming growth factor beta stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
    GO:0048048    embryonic eye morphogenesis    The process occurring in the embryo by which the anatomical structures of the post-embryonic eye are generated and organized.
    GO:0022617    extracellular matrix disassembly    A process that results in the breakdown of the extracellular matrix.
    GO:0030198    extracellular matrix organization    A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
    GO:0007507    heart development    The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
    GO:0001822    kidney development    The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
    GO:0001656    metanephros development    The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine.
    GO:0048050    post-embryonic eye morphogenesis    The process, occurring after embryonic development, by which the anatomical structures of the eye are generated and organized. The eye is the organ of sight.
    GO:0090287    regulation of cellular response to growth factor stimulus    Any process that modulates the rate, frequency, or extent of a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
    GO:0035582    sequestering of BMP in extracellular matrix    Confining a bone morphogenetic protein (BMP) to the extracellular matrix (ECM), such that it is separated from other components of the signaling pathway, including its cell surface receptor. Bone morphogenetic proteins (BMPs) are secreted as homodimers, non-covalently associated with N-terminal pro-peptides, and are targeted to the extracellular matrix through interaction with matrix proteins.
    GO:0035583    sequestering of TGFbeta in extracellular matrix    Confining TGFbeta to the extracellular matrix (ECM) such that it is separated from other components of the signaling pathway, including its cell surface receptor. TGFbeta is secreted as part of a latent complex that is targeted to the extracellular matrix through latent-TGFbeta-binding protein (LTBP)-mediated association with matrix proteins.
    GO:0001501    skeletal system development    The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
cellular component
    GO:0005604    basement membrane    A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0031012    extracellular matrix    A structure lying external to one or more cells, which provides structural support for cells or tissues.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0001527    microfibril    Extracellular matrix components occurring independently or along with elastin. Thought to have force-bearing functions in tendon. In addition to fibrillins, microfibrils may contain other associated proteins.
    GO:0005578    proteinaceous extracellular matrix    A layer consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or overlying cells such as endothelial and epithelial cells. The proteins are secreted by cells in the vicinity. An example of this component is found in Mus musculus.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    CA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Thr A:1572 - Pro A:1573   [ RasMol ]  
    Thr B:2572 - Pro B:2573   [ RasMol ]  
    Thr C:3572 - Pro C:3573   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]
    Biological Unit 3  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1uzj
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  FBN1_HUMAN | P35555
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  154700
    Disease InformationOMIM
  184900
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  FBN1_HUMAN | P35555
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        FBN1_HUMAN | P355551apj 1emn 1emo 1lmj 1uzk 1uzp 1uzq 2m74 2w86

(-) Related Entries Specified in the PDB File

1apj NMR STUDY OF THE TRANSFORMING GROWTH FACTOR BETA BINDINGPROTEIN-LIKE DOMAIN (TB MODULE/ 8-CYS DOMAIN), NMR,21 STRUCTURES
1emn NMR STUDY OF A PAIR OF FIBRILLIN CA==2 +== BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, MINIMIZED AVERAGE STRUCTURE
1emo NMR STUDY OF A PAIR OF FIBRILLIN CA==2 +== BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, 22 STRUCTURES
1lmj NMR STUDY OF THE FIBRILLIN-1 CBEGF12-13 PAIR OF CA2+BINDING EPIDERMAL GROWTH FACTOR -LIKE DOMAINS
1uzk X_RAY STRUCTURE OF THE INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, HOLO FORM
1uzp X_RAY STRUCTURE OF THE INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, SM BOUND FORM CBEGF23
1uzq X_RAY STRUCTURE OF THE INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, APO FORM CBEGF23